|
2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-l-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile adipate |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-01-26 00:00:00 |
| Sponsor | Incyte Corporation;1801 Augustine Cut-Off;Wilmington, Delaware, 19803 |
